Nutritional Outlook Vol. 29., No. 8

A look at the market data and functional ingredient innovations driving the next generation of nutrition bars.

The proposed notification requirement is straightforward, but its legal and commercial consequences are not.

With Peru's anchovy fishery opening its 2026 season with its lowest quota in a decade, Matts Johansen argues that aquaculture's growing appetite for omega-3s, not just El Niño, is what should actually be keeping supplement brands up at night.

Formulators are moving toward botanicals like ashwagandha, bacopa, saffron, and PEA that target the stress, cortisol, and nervous-system pathways behind restless nights.

Emerging plant protein sources are redefining how protein products are formulated.

A year-to-date look at the various forces pushing digestive health formulation toward more precise, mechanism-driven claims.

Why do promising nutraceutical ingredients underperform in human trials? This piece explores how phenotype-based recruitment aligns participant biology with mechanism, reducing signal dilution and producing more commercially meaningful efficacy evidence.

As a federal THC cap looms, industry leaders weigh in on what the new hemp definition means for brands and formulators.